KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $188.1 million.

  • Medpace Holdings' Free Cash Flow rose 278.27% to $188.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $681.9 million, marking a year-over-year increase of 1915.19%. This contributed to the annual value of $681.9 million for FY2025, which is 1915.19% up from last year.
  • Per Medpace Holdings' latest filing, its Free Cash Flow stood at $188.1 million for Q4 2025, which was up 278.27% from $235.5 million recorded in Q3 2025.
  • Medpace Holdings' Free Cash Flow's 5-year high stood at $235.5 million during Q3 2025, with a 5-year trough of $37.0 million in Q1 2022.
  • Moreover, its 5-year median value for Free Cash Flow was $104.6 million (2023), whereas its average is $111.9 million.
  • As far as peak fluctuations go, Medpace Holdings' Free Cash Flow crashed by 3677.54% in 2021, and later surged by 10857.96% in 2024.
  • Medpace Holdings' Free Cash Flow (Quarter) stood at $61.8 million in 2021, then skyrocketed by 106.29% to $127.4 million in 2022, then grew by 14.88% to $146.4 million in 2023, then grew by 25.01% to $183.0 million in 2024, then increased by 2.78% to $188.1 million in 2025.
  • Its Free Cash Flow stands at $188.1 million for Q4 2025, versus $235.5 million for Q3 2025 and $142.4 million for Q2 2025.